These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33664925)

  • 1. Transportal Technetium-99m Labeled Macroaggregated Albumin Scintigraphy to Quantify Occult Intrahepatic Microvascular Portosystemic Shunting.
    De la Garza-Ramos C; Muneer MS; Lewis JT; Harnois DM; Taner CB; Frey GT; Rosser B; Toskich BB
    Radiol Case Rep; 2021 Apr; 16(4):975-978. PubMed ID: 33664925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of intrahepatic portosystemic shunting after placement of a transjugular intrahepatic portosystemic shunt.
    Walser EM; Harris VM; Harman JT; Park HM; Siddiqui AR
    J Vasc Interv Radiol; 1996; 7(2):263-7. PubMed ID: 9007808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatopulmonary shunting on Tc99m-MAA liver mapping: correlation with dynamic cross-sectional imaging and description of different shunting patterns.
    Bermo M; Matesan MC; Itani M; Behnia F; Vesselle HJ
    Abdom Radiol (NY); 2018 Nov; 43(11):3001-3008. PubMed ID: 29632990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indicators of Lung Shunt Fraction Determined by Technetium-99 m Macroaggregated Albumin in Patients with Hepatocellular Carcinoma.
    Kallini JR; Gabr A; Hickey R; Kulik L; Desai K; Yang Y; Gates VL; Riaz A; Salem R; Lewandowski RJ
    Cardiovasc Intervent Radiol; 2017 Aug; 40(8):1213-1222. PubMed ID: 28280976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Hepatopulmonary Syndrome with Technetium-99m Macroaggregated Albumin Scintigraphy.
    Palot Manzil FF; Haq I; Wang X
    J Nucl Med Technol; 2022 May; ():. PubMed ID: 35610042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Retransplant Case for Hepatopulmonary Syndrome Without Liver Cirrhosis or Portosystemic Shunt After Living-Donor Liver Transplantation: A Case Report.
    Iwasaki S; Ueno T; Toyama C; Deguchi K; Nomura M; Saka R; Watanabe M; Tazuke Y; Bessho K; Okuyama H
    Transplant Proc; 2022 Mar; 54(2):552-555. PubMed ID: 35074161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (99m)Technetium-macroaggregated albumin perfusion lung scan versus contrast enhanced echocardiography in the diagnosis of the hepatopulmonary syndrome in children with chronic liver disease.
    El-Shabrawi MH; Omran S; Wageeh S; Isa M; Okasha S; Mohsen NA; Zekry O; E-Bartan G; El-Karaksy HM
    Eur J Gastroenterol Hepatol; 2010 Aug; 22(8):1006-12. PubMed ID: 20101183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraarterial Hepatic SPECT/CT Imaging Using 99mTc-Macroaggregated Albumin in Preparation for Radioembolization.
    Gates VL; Singh N; Lewandowski RJ; Spies S; Salem R
    J Nucl Med; 2015 Aug; 56(8):1157-62. PubMed ID: 26089551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of primary and secondary hepatic malignancies associated with hepatopulmonary shunting.
    Gaba RC; Zivin SP; Dikopf MS; Parvinian A; Casadaban LC; Lu Y; Bui JT
    Radiology; 2014 May; 271(2):602-12. PubMed ID: 24533871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncirrhotic Portal Hypertension due to Nodular Regenerative Hyperplasia Treated with Surgical Portacaval Shunt.
    Louwers LM; Bortman J; Koffron A; Stecevic V; Cohn S; Raofi V
    Case Rep Med; 2012; 2012():965304. PubMed ID: 22956964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of
    Allred JD; Niedbala J; Mikell JK; Owen D; Frey KA; Dewaraja YK
    EJNMMI Res; 2018 Jun; 8(1):50. PubMed ID: 29904808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatopulmonary syndrome: Case report of the evidence of intrapulmonary shunt on
    Zhou P; Yang J
    Hell J Nucl Med; 2024; 27(1):55-57. PubMed ID: 38629817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraportal infusion of 99mtechnetium-macro-aggregrated albumin particles and hepatocytes in rabbits: assessment of shunting and portal hemodynamic changes.
    Schneider A; Attaran M; Gratz KF; Bleck JS; Winkler M; Manns MP; Ott M
    Transplantation; 2003 Feb; 75(3):296-302. PubMed ID: 12589148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatopulmonary shunting in patients with primary and secondary liver tumors scheduled for radioembolization.
    Powerski MJ; Erxleben C; Scheurig-Münkler C; Geisel D; Heimann U; Hamm B; Gebauer B
    Eur J Radiol; 2015 Feb; 84(2):201-7. PubMed ID: 25483014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung shunt fraction calculation using
    Georgiou MF; Kuker RA; Studenski MT; Ahlman PP; Witte M; Portelance L
    EJNMMI Res; 2021 Sep; 11(1):96. PubMed ID: 34585259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nodular Regenerative Hyperplasia: A Case of Rare Prognosis.
    Lee M; Izzy M; Akki A; Tanaka K; Kalia H
    J Investig Med High Impact Case Rep; 2017; 5(1):2324709617690742. PubMed ID: 28491877
    [No Abstract]   [Full Text] [Related]  

  • 17. Transjugular intrahepatic portosystemic shunt: a successful treatment for hepatopulmonary syndrome.
    Selim KM; Akriviadis EA; Zuckerman E; Chen D; Reynolds TB
    Am J Gastroenterol; 1998 Mar; 93(3):455-8. PubMed ID: 9517657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer.
    Hamami ME; Poeppel TD; Müller S; Heusner T; Bockisch A; Hilgard P; Antoch G
    J Nucl Med; 2009 May; 50(5):688-92. PubMed ID: 19372479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodular regenerative hyperplasia of the liver: clinical and radiologic observations.
    Dachman AH; Ros PR; Goodman ZD; Olmsted WW; Ishak KG
    AJR Am J Roentgenol; 1987 Apr; 148(4):717-22. PubMed ID: 3548283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of time delay on the estimated lung shunt fraction on 99mTc-labeled MAA scintigraphy for 90Y microsphere treatment planning.
    De Gersem R; Maleux G; Vanbilloen H; Baete K; Verslype C; Haustermans K; Verbruggen A; Van Cutsem E; Deroose CM
    Clin Nucl Med; 2013 Dec; 38(12):940-2. PubMed ID: 24212439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.